physicians

Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts
Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts
Fierce Pharma
Pfizer
BridgeBio
Alnylam
FDA
clinical trials
ATTR-CM
physicians
tafamidis
Flag link:
The shrinking number of primary care physicians is reaching a tipping point
The shrinking number of primary care physicians is reaching a tipping point
Medical Marketing and Media
physicians
primary care
Flag link:
Doctor Practices Still Reeling From Loss Of Support Staff Since Pandemic’s Beginning
Doctor Practices Still Reeling From Loss Of Support Staff Since Pandemic’s Beginning
Forbes
physicians
labor shortage
pandemic
Flag link:
Medtronic, Cydar Treat First Patient in AI Pilot Program
Medtronic, Cydar Treat First Patient in AI Pilot Program
Medical Devices and Diagnostics Industry
Medtronic
Cydar Medical
artificial intelligence
Medtech
physicians
Flag link:
The BMJ's editor-in-chief wants action on pharma payments to leading doctor education groups in the UK
The BMJ's editor-in-chief wants action on pharma payments to leading doctor education groups in the UK
Fierce Pharma
BMJ
UK
pharma industry
physicians
physician payments
Flag link:
The hidden fee costing doctors millions every year
The hidden fee costing doctors millions every year
Medical Marketing and Media
physicians
insurers
lobbying
Flag link:
Will the doctor see you now? The health system’s changing landscape
Will the doctor see you now? The health system’s changing landscape
Medical Marketing and Media
physicians
patients
primary care
Flag link:
New devices could help Penumbra take market share, according to physician survey
New devices could help Penumbra take market share, according to physician survey
Medtech Dive
Medtech
Penumbra
physicians
Lightning Bolt 7
thrombectomy
Flag link:
Nuance’s mysterious pricing, speedier digital health evidence reviews, and new breakthrough devices
Nuance’s mysterious pricing, speedier digital health evidence reviews, and new breakthrough devices
Stat
digital health
Nuance Communications
physicians
Flag link:
Envision bankruptcy could be 1st canary in the physician services coal mine
Envision bankruptcy could be 1st canary in the physician services coal mine
Radiology Business
Envision Healthcare
bankruptcy
physicians
Radiology
Flag link:
Alzheimer’s doctors see promise, limits in Lilly’s latest drug data
Alzheimer’s doctors see promise, limits in Lilly’s latest drug data
BioPharma Dive
Eli Lilly
donanemab
Alzheimer's disease
physicians
Flag link:
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Medical Marketing and Media
Bayer
diabetes
chronic kidney disease
healthcare providers
physicians
Flag link:
Is pharma patient centric? Not according to most doctors
Is pharma patient centric? Not according to most doctors
Pharmaphorum
physicians
patients
Flag link:
Doctors largely comfortable with biosimilar drugs, but question economics: report
Doctors largely comfortable with biosimilar drugs, but question economics: report
BioPharma Dive
Cardinal Health
physicians
biosimilars
Flag link:
More than half of physicians admit to changing perceptions of a drug due to social media
More than half of physicians admit to changing perceptions of a drug due to social media
Fierce Pharma
social media
physicians
Flag link:
After staying away during pandemic, doctors return to lobby congress
After staying away during pandemic, doctors return to lobby congress
Medical Marketing and Media
AMA
physicians
lobbying
Flag link:
Years after the first US biosim launches, doctors still have their concerns: survey
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
biosimilars
PBMs
physicians
AbbVie
Humira
Amgen
Amjevita
Flag link:
5 Ways ChatGPT Will Change Healthcare Forever, For Better
5 Ways ChatGPT Will Change Healthcare Forever, For Better
Forbes
Healthcare
ChatGPT
artificial intelligence
physicians
data
wearables
Medtech
Flag link:
Docs likely to be 'cautious' when prescribing GSK's first-in-class anemia drug Jesduvroq, survey finds
Docs likely to be 'cautious' when prescribing GSK's first-in-class anemia drug Jesduvroq, survey finds
Fierce Pharma
GSK
physicians
anemia
Jesduvroq
Flag link:
For ALS patients, doctors, a new medicine reignites concerns about healthcare access
For ALS patients, doctors, a new medicine reignites concerns about healthcare access
BioPharma Dive
Amylyx
Relyvrio
ALS
patients
physicians
Flag link:

Pages